Market Highlights The global albumin market is expected to grow at an approximate CAGR of 6.1% during forecast period. Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the albumin (as excipient) market. For instance, in 2014, Novozymes Biopharma DK A/S announced that its albumin-based...